J. Uitto and D. Kouba, Cytokine modulation of extracellular matrix gene expression: relevance to fibrotic skin diseases, Journal of Dermatological Science, vol.24, pp.60-69, 2000.
DOI : 10.1016/S0923-1811(00)00143-2

F. Verrecchia and A. Mauviel, Control of connective tissue gene expression by TGF??: Role of smad proteins in fibrosis, Current Rheumatology Reports, vol.116, issue.2, pp.143-149, 2002.
DOI : 10.1007/s11926-002-0010-4

URL : https://hal.archives-ouvertes.fr/inserm-00147404

F. Verrecchia and A. Mauviel, Transforming Growth Factor-?? Signaling Through the Smad Pathway: Role in Extracellular Matrix Gene Expression and Regulation, Journal of Investigative Dermatology, vol.118, issue.2, pp.211-215, 2002.
DOI : 10.1046/j.1523-1747.2002.01641.x

F. Verrecchia and A. Mauviel, TGF-?? and TNF-??: antagonistic cytokines controlling type I collagen gene expression, Cellular Signalling, vol.16, issue.8, pp.873-880, 2004.
DOI : 10.1016/j.cellsig.2004.02.007

URL : https://hal.archives-ouvertes.fr/inserm-00147459

B. D. Kahan, J. Podbielski, K. L. Napoli, S. M. Katz, H. U. Meier-kriesche et al., IMMUNOSUPPRESSIVE EFFECTS AND SAFETY OF A SIROLIMUS/CYCLOSPORINE COMBINATION REGIMEN FOR RENAL TRANSPLANTATION1, Transplantation, vol.66, issue.8, pp.1040-1046, 1998.
DOI : 10.1097/00007890-199810270-00013

O. Pridohl, K. Heinemann, T. Hartwig, H. Witzigmann, P. Lamesch et al., Low-dose immunosuppression with FK 506 and sirolimus after liver transplantation: 1-year results, Transplantation Proceedings, vol.33, issue.7-8, pp.3229-3231, 2001.
DOI : 10.1016/S0041-1345(01)02373-9

A. C. Webster, V. W. Lee, J. R. Chapman, C. , and J. C. , Target of Rapamycin Inhibitors (Sirolimus and Everolimus) for Primary Immunosuppression of Kidney Transplant Recipients: A Systematic Review and Meta-Analysis of Randomized Trials, Transplantation, vol.81, issue.9, pp.1234-1248, 2006.
DOI : 10.1097/01.tp.0000219703.39149.85

J. Zhu, J. Wu, E. Frizell, S. L. Liu, R. Bashey et al., Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis, Gastroenterology, vol.117, issue.5, pp.1198-1204, 1999.
DOI : 10.1016/S0016-5085(99)70406-3

N. R. Simler, D. C. Howell, R. P. Marshall, N. R. Goldsack, P. S. Hasleton et al., The rapamycin analogue SDZ RAD attenuates bleomycin-induced pulmonary fibrosis in rats, European Respiratory Journal, vol.19, issue.6, pp.1124-1127, 2002.
DOI : 10.1183/09031936.02.00281602

E. Biecker, M. Neef, H. Sagesser, S. Shaw, A. Koshy et al., Nitric oxide synthase 1 is partly compensating for nitric oxide synthase 3 deficiency in nitric oxide synthase 3 knock-out mice and is elevated in murine and human cirrhosis, Liver International, vol.276, issue.4, pp.345-353, 2004.
DOI : 10.1016/0039-128X(75)90005-7

E. J. Brown, M. W. Albers, T. B. Shin, K. Ichikawa, C. T. Keith et al., A mammalian protein targeted by G1-arresting rapamycin???receptor complex, Nature, vol.369, issue.6483, pp.756-758, 1994.
DOI : 10.1038/369756a0

N. Hay and N. Sonenberg, Upstream and downstream of mTOR, Genes & Development, vol.18, issue.16, pp.1926-1945, 2004.
DOI : 10.1101/gad.1212704

J. Chung, C. J. Kuo, G. R. Crabtree, and J. Blenis, Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases, Cell, vol.69, issue.7, pp.1227-1236, 1992.
DOI : 10.1016/0092-8674(92)90643-Q

M. E. Cardenas, D. Zhu, and J. Heitman, Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin, Current Opinion in Nephrology and Hypertension, vol.4, issue.6, pp.472-477, 1995.
DOI : 10.1097/00041552-199511000-00002

S. N. Sehgal, J. S. Camardo, J. A. Scarola, M. , and B. T. , Rapamycin (sirolimus, rapamune), Current Opinion in Nephrology and Hypertension, vol.4, issue.6, pp.482-487, 1995.
DOI : 10.1097/00041552-199511000-00004

S. J. Chen, C. M. Artlett, S. A. Jimenez, and J. Varga, Modulation of human ??1(I) procollagen gene activity by interaction with Sp1 and Sp3 transcription factors in vitro, Gene, vol.215, issue.1, pp.101-110, 1998.
DOI : 10.1016/S0378-1119(98)00268-6

A. Mauviel, Y. Qiu-chen, W. Dong, C. H. Evans, and J. Uitto, Transcriptional interactions of transforming growth-factor-?? with pro-inflammatory cytokines, Current Biology, vol.3, issue.12, pp.822-831, 1993.
DOI : 10.1016/0960-9822(93)90216-B

URL : https://hal.archives-ouvertes.fr/inserm-00147456

M. Mudryj and B. De-crombrugghe, Deletion analysis of the mouse alpha 1 (III) collagen promoter, Nucleic Acids Research, vol.16, issue.15, pp.7513-7526, 1988.
DOI : 10.1093/nar/16.15.7513

N. C. Andrews and D. V. Faller, A rapid micrqpreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells, Nucleic Acids Research, vol.19, issue.9, p.2499, 1991.
DOI : 10.1093/nar/19.9.2499

A. Mauviel, Cytokine regulation of metalloproteinase gene expression, Journal of Cellular Biochemistry, vol.5, issue.4, pp.288-295, 1993.
DOI : 10.1002/jcb.240530404

URL : https://hal.archives-ouvertes.fr/inserm-00147455

M. Schorpp, M. G. Mattei, I. Herr, S. Gack, J. Schaper et al., Structural organization and chromosomal localization of the mouse collagenase type I gene, Biochemical Journal, vol.308, issue.1, pp.211-217, 1995.
DOI : 10.1042/bj3080211

M. Karin, Z. Liu, and E. Zandi, AP-1 function and regulation, Current Opinion in Cell Biology, vol.9, issue.2, pp.240-246, 1997.
DOI : 10.1016/S0955-0674(97)80068-3

D. Shegogue and M. Trojanowska, Mammalian Target of Rapamycin Positively Regulates Collagen Type I Production via a Phosphatidylinositol 3-Kinase-independent Pathway, Journal of Biological Chemistry, vol.279, issue.22, pp.23166-23175, 2004.
DOI : 10.1074/jbc.M401238200

M. Krupsky, P. P. Kuang, and R. H. Goldstein, Regulation of Type I Collagen mRNA by Amino Acid Deprivation in Human Lung Fibroblasts, Journal of Biological Chemistry, vol.272, issue.21, pp.13864-13868, 1997.
DOI : 10.1074/jbc.272.21.13864

M. Krupsky, A. Fine, J. L. Berk, and R. H. Goldstein, Retinoic acid-induced inhibition of type I collagen gene expression by human lung fibroblasts, Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, vol.1219, issue.2, pp.335-341, 1994.
DOI : 10.1016/0167-4781(94)90057-4

J. Varga, A. Diaz-perez, J. Rosenbloom, and S. A. Jimenez, PGE2 causes a coordinate decrease in the steady state levels of fibronectin and types I and III procollagen mRNAs in normal human dermal fibroblasts, Biochemical and Biophysical Research Communications, vol.147, issue.3, pp.1282-1288, 1987.
DOI : 10.1016/S0006-291X(87)80209-7

T. Peng, T. R. Golub, and D. M. Sabatini, The Immunosuppressant Rapamycin Mimics a Starvation-Like Signal Distinct from Amino Acid and Glucose Deprivation, Molecular and Cellular Biology, vol.22, issue.15, pp.5575-5584, 2002.
DOI : 10.1128/MCB.22.15.5575-5584.2002

Y. Asano, H. Ihn, K. Yamane, M. Jinnin, Y. Mimura et al., Differential effects of the immunosuppressant FK-506 on human ?2(I) collagen gene expression and transforming growth factor ? signaling in normal and scleroderma fibroblasts, Arthritis & Rheumatism, vol.107, issue.4, pp.1237-1247, 2005.
DOI : 10.1002/art.20934

B. Eckes, C. Mauch, G. Huppe, and T. Krieg, 1(I) collagen and fibronectin in activated fibroblasts derived from patients with systemic scleroderma, Biochemical Journal, vol.315, issue.2, pp.549-554, 1996.
DOI : 10.1042/bj3150549

S. Huang, L. Shu, M. B. Dilling, J. Easton, F. C. Harwood et al., Sustained Activation of the JNK Cascade and Rapamycin-Induced Apoptosis Are Suppressed by p53/p21Cip1, Molecular Cell, vol.11, issue.6, pp.1491-1501, 2003.
DOI : 10.1016/S1097-2765(03)00180-1

F. Verrecchia, M. Pessah, A. Atfi, and A. Mauviel, Tumor Necrosis Factor-?? Inhibits Transforming Growth Factor-?? /Smad Signaling in Human Dermal Fibroblasts via AP-1 Activation, Journal of Biological Chemistry, vol.275, issue.39, pp.30226-30231, 2000.
DOI : 10.1074/jbc.M005310200

URL : https://hal.archives-ouvertes.fr/inserm-00150046

F. Verrecchia, C. Tacheau, E. F. Wagner, and A. Mauviel, A Central Role for the JNK Pathway in Mediating the Antagonistic Activity of Pro-inflammatory Cytokines against Transforming Growth Factor-??-driven SMAD3/4-specific Gene Expression, Journal of Biological Chemistry, vol.278, issue.3, pp.1585-1593, 2003.
DOI : 10.1074/jbc.M206927200

J. Wendling, A. Marchand, A. Mauviel, and F. Verrecchia, 5-Fluorouracil Blocks Transforming Growth Factor-??-Induced ??2 Type I Collagen Gene (COL1A2) Expression in Human Fibroblasts via c-Jun NH2-Terminal Kinase/Activator Protein-1 Activation, Molecular Pharmacology, vol.64, issue.3, pp.707-713, 2003.
DOI : 10.1124/mol.64.3.707